Non-invasive Prenatal Testing Market Report

Global Non-invasive Prenatal Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 10, 2022
  • PAGES：150
  • REPORT CODE：GMM805330
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Non-invasive Prenatal Testing market report explains the definition, types, applications, major countries, and major players of the Non-invasive Prenatal Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Illumina

    • PerkinElmer

    • Roche

    • Natera

    • LifeCodexx

    • BGI Genomics

    • Sequenom

    By Type:

    • First trimester

    • Second trimester

    • Third trimester

    • Post-term

    By End-User:

    • Hospital

    • Laboratory

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Non-invasive Prenatal Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Non-invasive Prenatal Testing Outlook to 2028- Original Forecasts

    • 2.2 Non-invasive Prenatal Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Non-invasive Prenatal Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Non-invasive Prenatal Testing Market- Recent Developments

    • 6.1 Non-invasive Prenatal Testing Market News and Developments

    • 6.2 Non-invasive Prenatal Testing Market Deals Landscape

    7 Non-invasive Prenatal Testing Raw Materials and Cost Structure Analysis

    • 7.1 Non-invasive Prenatal Testing Key Raw Materials

    • 7.2 Non-invasive Prenatal Testing Price Trend of Key Raw Materials

    • 7.3 Non-invasive Prenatal Testing Key Suppliers of Raw Materials

    • 7.4 Non-invasive Prenatal Testing Market Concentration Rate of Raw Materials

    • 7.5 Non-invasive Prenatal Testing Cost Structure Analysis

      • 7.5.1 Non-invasive Prenatal Testing Raw Materials Analysis

      • 7.5.2 Non-invasive Prenatal Testing Labor Cost Analysis

      • 7.5.3 Non-invasive Prenatal Testing Manufacturing Expenses Analysis

    8 Global Non-invasive Prenatal Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Non-invasive Prenatal Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Non-invasive Prenatal Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Non-invasive Prenatal Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-invasive Prenatal Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global First trimester Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Second trimester Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Third trimester Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Post-term Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-invasive Prenatal Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Laboratory Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Non-invasive Prenatal Testing Market Analysis and Outlook till 2022

    • 10.1 Global Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.2.2 Canada Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.2.3 Mexico Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.2 UK Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.3 Spain Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.4 Belgium Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.5 France Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.6 Italy Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.7 Denmark Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.8 Finland Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.9 Norway Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.10 Sweden Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.11 Poland Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.12 Russia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.3.13 Turkey Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.2 Japan Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.3 India Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.4 South Korea Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.5 Pakistan Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.7 Indonesia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.8 Thailand Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.9 Singapore Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.10 Malaysia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.11 Philippines Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.4.12 Vietnam Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.2 Colombia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.3 Chile Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.4 Argentina Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.5 Venezuela Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.6 Peru Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.5.8 Ecuador Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.6.2 Kuwait Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.6.3 Oman Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.6.4 Qatar Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.7.2 South Africa Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.7.3 Egypt Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.7.4 Algeria Non-invasive Prenatal Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Non-invasive Prenatal Testing Consumption (2017-2022)

      • 10.8.2 New Zealand Non-invasive Prenatal Testing Consumption (2017-2022)

    11 Global Non-invasive Prenatal Testing Competitive Analysis

    • 11.1 Illumina

      • 11.1.1 Illumina Company Details

      • 11.1.2 Illumina Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Illumina Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.1.4 Illumina Non-invasive Prenatal Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 PerkinElmer

      • 11.2.1 PerkinElmer Company Details

      • 11.2.2 PerkinElmer Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 PerkinElmer Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.2.4 PerkinElmer Non-invasive Prenatal Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Roche

      • 11.3.1 Roche Company Details

      • 11.3.2 Roche Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Roche Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.3.4 Roche Non-invasive Prenatal Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Natera

      • 11.4.1 Natera Company Details

      • 11.4.2 Natera Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Natera Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.4.4 Natera Non-invasive Prenatal Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 LifeCodexx

      • 11.5.1 LifeCodexx Company Details

      • 11.5.2 LifeCodexx Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 LifeCodexx Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.5.4 LifeCodexx Non-invasive Prenatal Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 BGI Genomics

      • 11.6.1 BGI Genomics Company Details

      • 11.6.2 BGI Genomics Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 BGI Genomics Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.6.4 BGI Genomics Non-invasive Prenatal Testing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sequenom

      • 11.7.1 Sequenom Company Details

      • 11.7.2 Sequenom Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sequenom Non-invasive Prenatal Testing Main Business and Markets Served

      • 11.7.4 Sequenom Non-invasive Prenatal Testing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Non-invasive Prenatal Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global Non-invasive Prenatal Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global First trimester Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Second trimester Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Third trimester Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Post-term Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Non-invasive Prenatal Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Non-invasive Prenatal Testing Market Analysis and Outlook to 2028

    • 13.1 Global Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.5 France Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.3 India Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Non-invasive Prenatal Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Non-invasive Prenatal Testing

    • Figure of Non-invasive Prenatal Testing Picture

    • Table Global Non-invasive Prenatal Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Non-invasive Prenatal Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global First trimester Consumption and Growth Rate (2017-2022)

    • Figure Global Second trimester Consumption and Growth Rate (2017-2022)

    • Figure Global Third trimester Consumption and Growth Rate (2017-2022)

    • Figure Global Post-term Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratory Consumption and Growth Rate (2017-2022)

    • Figure Global Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Table North America Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure United States Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure Germany Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure UK Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure France Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table APAC Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure China Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure India Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table South America Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure Brazil Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table GCC Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure Bahrain Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table Africa Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure Nigeria Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania Non-invasive Prenatal Testing Consumption by Country (2017-2022)

    • Figure Australia Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Non-invasive Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Table Illumina Company Details

    • Table Illumina Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Non-invasive Prenatal Testing Main Business and Markets Served

    • Table Illumina Non-invasive Prenatal Testing Product Portfolio

    • Table PerkinElmer Company Details

    • Table PerkinElmer Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table PerkinElmer Non-invasive Prenatal Testing Main Business and Markets Served

    • Table PerkinElmer Non-invasive Prenatal Testing Product Portfolio

    • Table Roche Company Details

    • Table Roche Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Non-invasive Prenatal Testing Main Business and Markets Served

    • Table Roche Non-invasive Prenatal Testing Product Portfolio

    • Table Natera Company Details

    • Table Natera Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natera Non-invasive Prenatal Testing Main Business and Markets Served

    • Table Natera Non-invasive Prenatal Testing Product Portfolio

    • Table LifeCodexx Company Details

    • Table LifeCodexx Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table LifeCodexx Non-invasive Prenatal Testing Main Business and Markets Served

    • Table LifeCodexx Non-invasive Prenatal Testing Product Portfolio

    • Table BGI Genomics Company Details

    • Table BGI Genomics Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BGI Genomics Non-invasive Prenatal Testing Main Business and Markets Served

    • Table BGI Genomics Non-invasive Prenatal Testing Product Portfolio

    • Table Sequenom Company Details

    • Table Sequenom Non-invasive Prenatal Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sequenom Non-invasive Prenatal Testing Main Business and Markets Served

    • Table Sequenom Non-invasive Prenatal Testing Product Portfolio

    • Figure Global First trimester Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Second trimester Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Third trimester Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Post-term Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Table North America Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure China Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Non-invasive Prenatal Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Non-invasive Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US